Fundraising Fox

OncoMyx Therapeutics

Phoenix, US · Founded 2018 · Delaware corporation

Biotech

Founders & leadership

OncoMyx Therapeutics was founded in 2018 by Douglas Grant McFadden, Ph.D. and Steven J. Potts, Ph.D..

DG
Douglas Grant McFadden, Ph.D.Co-founder
SJ
Steven J. Potts, Ph.D.President and Chief Executive Officer
TX
Ting XiaoNamed on SEC filing
JR
Jason RushtonNamed on SEC filing
KD
Kanad Das, Ph.D.Named on SEC filing
MG
Michael G. WoodNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$58M disclosed across 2 rounds · 2019–2021

▶$50MraisedDec 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven J. Potts, Ph.D.Executive Officer, Director
  • Kanad Das, Ph.D.Director
  • Ting Xiao, C.F.A., F.R.M.Director
  • Benjamin Rovinski, Ph.D.Director
  • Widya Mulyasasmita, Ph.D.Director
  • Charles M. Baum, M.D., Ph.D.Director
  • Leslie Sharp, Ph.D.Executive Officer
Offering amount
$50M
Amount sold
$50M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedJun 2019 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ting XiaoDirector
  • Jason RushtonDirector
  • Douglas Grant McFadden, Ph.D.Director
  • Kanad Das, Ph.D.Director
  • Steven J. Potts, Ph.D.Director, Executive Officer
  • Michael G. WoodExecutive Officer
Offering amount
$25M
Amount sold
$8M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded OncoMyx Therapeutics?
OncoMyx Therapeutics was founded by Douglas Grant McFadden, Ph.D., Steven J. Potts, Ph.D. in 2018.
How much funding has OncoMyx Therapeutics raised?
OncoMyx Therapeutics has disclosed $58M raised across 2 rounds.
Where is OncoMyx Therapeutics headquartered?
OncoMyx Therapeutics is headquartered in Phoenix, US.